Jointown Pharmaceutical Group Co., Ltd (SHA:600998)
China flag China · Delayed Price · Currency is CNY
4.970
-0.070 (-1.39%)
Sep 11, 2026, 3:00 PM CST

SHA:600998 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
21,86318,81417,39016,94917,17614,702
Short-Term Investments
15.11124.0315.1195.0190289.15
Trading Asset Securities
605.1974.16972.3490.03319.723,597
Cash & Short-Term Investments
22,48319,01218,37817,13417,58618,588
Cash Growth
32.50%3.45%7.26%-2.57%-5.39%24.51%
Accounts Receivable
37,95232,67531,62729,37530,51128,224
Other Receivables
2,5233,7893,8813,1592,3953,029
Receivables
40,52236,49035,54432,58232,90731,305
Inventory
29,09630,25422,85120,11417,21315,517
Prepaid Expenses
88.4282.4817.6416.8-22.94
Other Current Assets
7,4339,4547,4355,7797,9525,737
Total Current Assets
99,62395,29284,22575,62575,65871,170
Property, Plant & Equipment
9,2969,3108,9788,9638,6488,521
Long-Term Investments
4,8674,5514,0923,5523,2982,413
Goodwill
1,3591,348799.37759.68813.38581.43
Other Intangible Assets
2,4212,5252,1121,8951,8632,195
Long-Term Deferred Tax Assets
935.22820.33658.83476.42434.7288.42
Long-Term Deferred Charges
468.34364.19224.97283.7261.01196.38
Other Long-Term Assets
1,8072,1971,3061,2331,336570.62
Total Assets
120,775116,407102,39692,78992,31285,936

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
55,46954,07546,51040,10139,29534,158
Accrued Expenses
741.41942.39810.71786.92780.82631.62
Short-Term Debt
15,98311,4659,93610,12211,49313,055
Current Portion of Long-Term Debt
351.6809.981,3892,040413.421,767
Current Portion of Leases
309.19289.47170.8278.6579.2187.16
Current Income Taxes Payable
203.98331.38545.81267.28306.73178.7
Current Unearned Revenue
1,6042,8481,6911,7032,502966.06
Other Current Liabilities
5,2115,5895,3504,9674,8144,551
Total Current Liabilities
79,87476,35066,40360,06659,68455,394
Long-Term Debt
2,2051,6431,0182,3362,9802,379
Long-Term Leases
774.63853.33698.94170.99195.64180.29
Long-Term Unearned Revenue
289.01271.61233.6244.45306.49343.39
Long-Term Deferred Tax Liabilities
428.06377.11346.58378.47459.6566.11
Other Long-Term Liabilities
25.5544.24102.73116.25--
Total Liabilities
83,59679,54068,80363,31263,62658,863

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
5,0425,0425,0423,9091,8741,874
Additional Paid-In Capital
5,1755,1925,2076,3538,2058,056
Retained Earnings
16,86716,75315,58514,05412,95011,546
Treasury Stock
-345.89-461.77-632.46-581.86-774.24-614.82
Comprehensive Income & Other
245.2257.3269.21248.37402.59564.73
Total Common Equity
26,98426,78325,47123,98322,65721,426
Minority Interest
8,4248,3136,3505,4944,0463,664
Shareholders' Equity
37,17936,86833,59329,47728,68527,073
Total Liabilities & Equity
120,775116,407102,39692,78992,31285,936

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
19,62315,06113,21214,74715,16217,469
Net Cash (Debt)
2,8603,9525,1652,3872,4241,119
Net Cash Growth
85.52%-23.50%116.38%-1.52%116.56%-
Net Cash Per Share
0.550.771.030.470.460.22
Filing Date Shares Outstanding
5,2034,9864,9865,0264,9124,963
Total Common Shares Outstanding
5,2034,9864,9865,0264,9454,963
Working Capital
19,74818,94217,82215,55915,97315,775
Book Value Per Share
5.195.375.114.774.544.28
Tangible Book Value
23,20422,91022,56021,32819,98118,649
Tangible Book Value Per Share
4.464.594.524.244.003.72
Buildings
8,8228,7298,4548,2357,5156,536
Machinery
3,5063,9893,3693,2192,9652,779
Construction In Progress
578.75688.25383.92634.92865.371,523